Applera Declares $0.0425 Dividend for ABI Stock

Aug 18, 2006

NEW YORK (GenomeWeb News) - Applera said today that its board has declared a regular quarterly dividend of $0.0425 per share for Applied Biosystems stock.

The dividend is payable on Oct. 2 to shareholders of record as of Sept. 1.

Breaking News

Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test
Decode Study Identifies Proteomic Predictors of All-Cause Mortality
In Brief This Week: Natera, Bruker, Bayer, and More
New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More
People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More
Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.

Applera Declares $0.0425 Dividend for ABI Stock

Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test

Decode Study Identifies Proteomic Predictors of All-Cause Mortality

In Brief This Week: Natera, Bruker, Bayer, and More

New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More

People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More

Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test